Publications
P182
Tetrahedron Lett. 2018, 59, 3519-3523.
Novel approach towards 3,7-disubstituted 1,6-naphthyridin-4(1H)-ones exploiting cross-coupling and SNAr reactions of a dihalogenated compound.
doi: 10.1016/j.tetlet.2018.08.013
P168
X-Ray Struct. Anal. Online 2017, 33, 41-43.
Crystal structure of N-(7-{[2-(dimethylamino)ethyl]amino}-1-methyl-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-3,4,5-trimethoxybenzamide.
doi: 10.2116/xraystruct.33.41
P156
Eur. J. Med. Chem. 2016, 119, 17-33.
Novel 1,6-naphthyridin-2(1H)-ones as potential anticancer agents targeting Hsp90.
doi: 10.1016/j.ejmech.2016.04.050
P141
Tetrahedron 2015, 71, 3303-3313.
Efficient one-pot synthesis of 3,7-disubstituted 1,6-naphthyridin-2(1H)-ones through regioselective palladium-catalyzed cross-coupling and SNAr reactions.
doi: 10.1016/j.tet.2015.03.110
P140
Mar. Drugs 2015, 13, 4934-48.
The Marine-Derived Fungus Clonostachys rosea, Source of a Rare Conjugated 4-Me-6E,8E-hexadecadienoic Acid Reducing Viability of MCF-7 Breast Cancer Cells and Gene Expression of Lipogenic Enzymes.
doi: 10.3390/md13084934
P125
Eur. J. Org. Chem. 2014, 7, 1487-1495.
Differential functionalization of 1,6-naphthyridin-2(1H)-ones through sequential one-pot Suzuki-Miyaura cross-couplings.
P114
ACS Med. Chem. Lett., 2013, 4, 288-292.
Discovery of a novel broad-spectrum antifungal agent, derived from albaconazole.
P113
Eur. J. Med. Chem. 2013, 59, 283-295.
Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases.
P112
J. Het. Chem., 2013, 50, 1187-1197.
Efficient new synthesis of N-arylbenzo[b]furo[3,2-d]pyrimidin-4-amines and their benzo[b]thieno[3,2-d]pyrimidin-4-amine analogues via a microwave-assisted Dimroth rearrangement.
P107
Eur. J. Med. Chem., 2012, 58, 171-183.
Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors.
P100
Tetrahedron Lett., 2012, 53, 944-947.
First synthesis of 4-aminopyrido[2',3':4,5]furo[3,2-d]pyrimidines.
P96
ChemMedChem, 2011, 6, 1806-1815.
Design, synthesis and biological evaluation of 1-[(biarylmethyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as potent antifungal agents: new insights into structure-activity relationships.
P92
Tetrahedron, 2011, 67, 4767-4773.
A convenient route to functionalized 3-amino-N-methylfuro[3,2-b]pyridine-2-carboxamides.
P91
ChemMedChem, 2011, 6, 816-825.
Design, synthesis and in vitro antifungal activity of 1-[(4-substituted benzyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols.
P87
J. Enzym. Inhib. Med. Chem., 2011, 26(2), 261-269.
Synthesis and in vitro antifungal evaluation of 2-(2,4-difluorophenyl)-1-[(1H-indol-3-ylmethyl)methylamino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols.
P86
Bioorg. Med. Chem. Lett., 2010, 20, 5203-5206.
Synthesis of N-aryl-3-(indol-3-yl)propanamides and their immunosuppressive activities.
P84
Tetrahedron, 2010, 66, 4490-4494.
A convenient route to functionalized 3-amino-6-bromofuro[3,2-b]pyridine-2-carboxamides.
P78
J. Pharmacol. Exp. Ther., 2009, 331(2), 710-716.
A novel indole-3-propanamide exerts its immunosuppressive activity by inhibiting JAK3 in T cells.
P75
Tetrahedron Lett., 2009, 50(41), 5729-5732.
A convenient synthesis of 5-arylamino-4H-pyran-4-ones using palladium-catalyzed amination.
P65
J. Enz. Inh. Med. Chem. 2008, 23(5), 629-640.
Design, synthesis and evaluation of new 6-substituted-5-benzyloxy-4-oxo-4H-pyran-2-carboxamides as potential Src inhibitors.
Brevets
B12.
Nouveaux dérivés indoliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
Brevet Français, déposé le 18 octobre 2006, sous le n° 06/09114.
B11.
Nouveaux dérivés indoliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
Brevet Français, déposé le 18 octobre 2006, sous le n° 06/09113.
B4.
Nouveaux dérivés de 3-aryl-2,5-dihydroxy-1,4-benzoquinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
Fr. Pat. n° 02.01409, 06 Feb. 2002.